Product Information

IVABRADINE HCL 7.5 MG TABLET is a generic product labeled by Ingenus Pharmaceuticals LLC, priced at $0.6026 per EA under NDC 50742036360. Its NADAC has been published 108 times since Oct 23, 2024.

FDA first approved this application on Dec 30, 2021. Its Orange Book therapeutic-equivalence code is AB — FDA rates it therapeutically equivalent to (substitutable for) its reference product.

IVABRADINE HCL 7.5 MG TABLET

IVABRADINE
$0.6026per EA

Strength

7.5 mg/1

NDC

50742036360

Classification

Generic

Dosage Form

TABLET, FILM COATED

Route

ORAL

Effective Date

10/21/2026

Active Ingredients

IVABRADINE HYDROCHLORIDE

Approval Type

Generic (ANDA)

FDA Application

ANDA214051

FDA Approved

12/30/2021

TE Code

AB

On Market Since

7/15/2024

Pharmacological Classes

Hyperpolarization-activated Cyclic Nucleotide-gated Channel Antagonists
Hyperpolarization-activated Cyclic Nucleotide-gated Channel Blocker

Price Statistics

The NADAC for IVABRADINE HCL 7.5 MG TABLET has been published 108 times since Oct 23, 2024, and over the history we have for it it has declined 90.3%. The table below summarizes its recorded NADAC range and movement.

Current price$0.6026 per EA
All-time high$6.2147 (Nov 13, 2024)
All-time low$0.6026 (Oct 21, 2026)
52-week high$2.4527
52-week low$0.6026
Median price$2.5028
Average price$2.5533
Largest weekly change-25.7% (Feb 18, 2026)
Weeks tracked108
Tracking sinceOct 23, 2024

Price History

1W

0.0%

1M

-5.8%

3M

-8.8%

6M

-19.7%

1Y

-75.9%

3Y

N/A

5Y

N/A

All

-90.3%

Generic Alternatives

No other NADAC-published product shares this drug's active ingredient and strength in a comparable dosage form. Compare the broader picture on the IVABRADINE market page.

Lowest-Cost Alternatives

No alternatives available

No alternatives found with the same active ingredient and strength in a comparable dosage form.

Continue researching this drug

Use these direct paths to move from a single NDC into the surrounding market, manufacturer, class, and trend context.

Frequently asked questions

What is the NADAC price of IVABRADINE HCL 7.5 MG TABLET?

The current National Average Drug Acquisition Cost (NADAC) for IVABRADINE HCL 7.5 MG TABLET, manufactured by Ingenus Pharmaceuticals LLC, is $0.6026 per EA (NDC 50742036360), effective Nov 11, 2026.

How has the price of IVABRADINE HCL 7.5 MG TABLET changed over time?

Over the history we have for it, the NADAC for IVABRADINE HCL 7.5 MG TABLET has declined 90.3%. It has been tracked across 108 weekly CMS publications since Oct 23, 2024.

What are the highest and lowest recorded NADAC prices for IVABRADINE HCL 7.5 MG TABLET?

Since Oct 23, 2024, the NADAC for IVABRADINE HCL 7.5 MG TABLET has ranged from a low of $0.6026 (Oct 21, 2026) to a high of $6.2147 (Nov 13, 2024), with a median of $2.5028 per EA.

Are there cheaper alternatives to IVABRADINE HCL 7.5 MG TABLET?

No other NADAC-published product currently shares the active ingredient and strength of IVABRADINE HCL 7.5 MG TABLET in a comparable dosage form, so no direct lower-cost alternative is listed.

Who manufactures IVABRADINE HCL 7.5 MG TABLET?

IVABRADINE HCL 7.5 MG TABLET (NDC 50742036360) is labeled by Ingenus Pharmaceuticals LLC, and CMS classifies it as a generic product.